137 related articles for article (PubMed ID: 8668952)
1. Cytokines in rheumatoid arthritis. Localization in arthritic joint tissue and regulation in vitro.
Deleuran BW
Scand J Rheumatol Suppl; 1996; 104():1-34. PubMed ID: 8668952
[No Abstract] [Full Text] [Related]
2. [Interleukins network in rheumatoid arthritis pathophysiology: beyond proinflammatory cytokines].
Sánchez-Ramón S; López-Longo FJ; Carreño L
Reumatol Clin; 2011 Mar; 6S3():S20-4. PubMed ID: 21794767
[TBL] [Abstract][Full Text] [Related]
3. Effects of disease-modifying antirheumatic drug treatment on the expression of RANKL and osteoprotegerin in synovial tissue: comment on the article by Haynes et al.
Catrina AI; Klareskog L
Arthritis Rheum; 2008 Nov; 59(11):1685; author reply 1685-6. PubMed ID: 18975354
[No Abstract] [Full Text] [Related]
4. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis.
Ounissi-Benkalha H; Pelletier JP; Tardif G; Mineau F; Jolicoeur FC; Ranger P; Martel-Pelletier J
J Rheumatol; 1996 Jan; 23(1):16-23. PubMed ID: 8838503
[TBL] [Abstract][Full Text] [Related]
5. Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.
Bramlage CP; Kaps C; Ungethüm U; Bramlage P; Koziolek M; Wessels J; Krenn V; Pruss A; Müller GA; Strutz F; Burmester GR; Häupl T
Scand J Rheumatol; 2008; 37(6):401-9. PubMed ID: 18830904
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of rheumatoid arthritis is associated with a reduction in synovial membrane cytokines and cell adhesion molecule expression.
Smith MD; Slavotinek J; Au V; Weedon H; Parker A; Coleman M; Roberts-Thomson PJ; Ahern MJ
Rheumatology (Oxford); 2001 Sep; 40(9):965-77. PubMed ID: 11561106
[TBL] [Abstract][Full Text] [Related]
7. A novel inhibitor of I-kappaB kinase beta ameliorates experimental arthritis through downregulation of proinflammatory cytokines in arthritic joints.
Tanaka S; Toki T; Yokoyama M; Shimizu H; Yamasaki T; Yoneda Y; Muro F; Yasukochi T; Iimura S; Morishita K
Biol Pharm Bull; 2014; 37(1):87-95. PubMed ID: 24389485
[TBL] [Abstract][Full Text] [Related]
8. Synovial synoviolin in relation to response to TNF blockade in patients with rheumatoid arthritis and psoriatic arthritis.
Klaasen R; Wijbrandts CA; van Kuijk AW; Pots D; Gerlag DM; Tak PP
Ann Rheum Dis; 2012 Jul; 71(7):1260-1. PubMed ID: 22345123
[No Abstract] [Full Text] [Related]
9. Anti-arthritic and disease modifying activity of Terminalia chebula Retz. in experimental models.
Nair V; Singh S; Gupta YK
J Pharm Pharmacol; 2010 Dec; 62(12):1801-6. PubMed ID: 21054408
[TBL] [Abstract][Full Text] [Related]
10. The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis.
Feldmann M; Brennan FM; Williams RO; Woody JN; Maini RN
Best Pract Res Clin Rheumatol; 2004 Feb; 18(1):59-80. PubMed ID: 15123038
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-18: a therapeutic target in rheumatoid arthritis?
McInnes IB; Liew FY; Gracie JA
Arthritis Res Ther; 2005; 7(1):38-41. PubMed ID: 15642152
[TBL] [Abstract][Full Text] [Related]
12. Intraarticular variability of synovial membrane histology, immunohistology, and cytokine mRNA expression in patients with rheumatoid arthritis.
Kirkham B; Portek I; Lee CS; Stavros B; Lenarczyk A; Lassere M; Edmonds J
J Rheumatol; 1999 Apr; 26(4):777-84. PubMed ID: 10229396
[TBL] [Abstract][Full Text] [Related]
13. Ethanolic extract of Kaempferia parviflora interrupts the mechanisms-associated rheumatoid arthritis in SW982 culture model via p38/STAT1 and STAT3 pathways.
Kongdang P; Jaitham R; Thonghoi S; Kuensaen C; Pradit W; Ongchai S
Phytomedicine; 2019 Jun; 59():152755. PubMed ID: 31005814
[TBL] [Abstract][Full Text] [Related]
14. [Adhesion molecule in pathogenesis of rheumatoid arthritis].
Origuchi T; Eguchi K
Nihon Rinsho; 2005 Jan; 63 Suppl 1():200-7. PubMed ID: 15799346
[No Abstract] [Full Text] [Related]
15. Regulators of cytokine signalling in rheumatoid arthritis.
Rahman A
Rheumatology (Oxford); 2007 Dec; 46(12):1745-6. PubMed ID: 17986480
[No Abstract] [Full Text] [Related]
16. Etanercept decreases synovial expression of tumour necrosis factor-α and lymphotoxin-α in rheumatoid arthritis.
Neregård P; Krishnamurthy A; Revu S; Engström M; af Klint E; Catrina AI
Scand J Rheumatol; 2014; 43(2):85-90. PubMed ID: 24313444
[TBL] [Abstract][Full Text] [Related]
17. Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade.
Heinhuis B; Koenders MI; van Riel PL; van de Loo FA; Dinarello CA; Netea MG; van den Berg WB; Joosten LA
Ann Rheum Dis; 2011 Apr; 70(4):660-7. PubMed ID: 21187297
[TBL] [Abstract][Full Text] [Related]
18. Targeting interleukin-33 in rheumatoid arthritis.
Rong C; Hu W; Wu FR; Chen FH
Rheumatol Int; 2013 May; 33(5):1377-8. PubMed ID: 22210269
[No Abstract] [Full Text] [Related]
19. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
Christodoulou C; Choy EH
Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
[TBL] [Abstract][Full Text] [Related]
20. [Cytokines in rheumatoid arthritis. I. Proinflammatory cytokines].
Klimiuk PA; Sierakowski S
Pol Merkur Lekarski; 2001 Dec; 11(66):510-3. PubMed ID: 11899850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
